Key Financial Data Of Reporting Company

TORII PHARMACEUTICAL CO., LTD. - Filing #7340452

Concept As at
2024-03-31
2024-01-01 to
2024-03-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2023-03-31
2023-01-01 to
2023-03-31
Key financial data of reporting company
Business results of reporting company
Net sales
13,451,000,000 JPY
54,638,000,000 JPY
11,811,000,000 JPY
Ordinary profit (loss)
1,166,000,000 JPY
5,307,000,000 JPY
-404,000,000 JPY
Profit (loss)
878,000,000 JPY
4,119,000,000 JPY
-288,000,000 JPY
Equity in earnings (losses) of affiliates if equity method is applied
JPY
JPY
JPY
Share capital
5,190,000,000 JPY
5,190,000,000 JPY
5,190,000,000 JPY
Total number of issued shares
28,800,000 xbrli:shares
28,800,000 xbrli:shares
28,800,000 xbrli:shares
Net assets
119,041,000,000 JPY
120,134,000,000 JPY
117,067,000,000 JPY
Total assets
132,947,000,000 JPY
133,432,000,000 JPY
129,577,000,000 JPY
Dividend paid per share
120.00
Basic earnings (loss) per share
31.27
146.60
-10.28
Diluted earnings per share
Equity-to-asset ratio
0.895 xbrli:pure
0.900 xbrli:pure
0.903 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.